Fairfield Financial Advisors LTD Makes New $40,000 Investment in CVS Health Co. (NYSE:CVS)

Fairfield Financial Advisors LTD purchased a new stake in CVS Health Co. (NYSE:CVS) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 685 shares of the pharmacy operator’s stock, valued at approximately $40,000.

A number of other hedge funds have also modified their holdings of CVS. Wedmont Private Capital lifted its position in CVS Health by 0.8% in the 1st quarter. Wedmont Private Capital now owns 19,225 shares of the pharmacy operator’s stock valued at $1,410,000 after purchasing an additional 146 shares during the last quarter. Moody National Bank Trust Division increased its stake in shares of CVS Health by 0.7% in the first quarter. Moody National Bank Trust Division now owns 22,268 shares of the pharmacy operator’s stock valued at $1,776,000 after purchasing an additional 150 shares during the period. Landmark Financial Advisors LLC raised its holdings in shares of CVS Health by 3.8% during the fourth quarter. Landmark Financial Advisors LLC now owns 4,166 shares of the pharmacy operator’s stock valued at $329,000 after buying an additional 153 shares during the last quarter. Garland Capital Management Inc. boosted its position in shares of CVS Health by 0.3% during the second quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator’s stock worth $3,591,000 after buying an additional 160 shares during the period. Finally, Sepio Capital LP grew its holdings in CVS Health by 1.7% in the 4th quarter. Sepio Capital LP now owns 9,907 shares of the pharmacy operator’s stock worth $782,000 after buying an additional 163 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Trading Up 0.8 %

NYSE CVS opened at $57.98 on Monday. The firm’s 50 day moving average price is $58.28 and its two-hundred day moving average price is $63.00. The stock has a market cap of $72.79 billion, a price-to-earnings ratio of 10.19, a PEG ratio of 0.79 and a beta of 0.53. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same period in the previous year, the firm earned $2.21 earnings per share. CVS Health’s quarterly revenue was up 2.6% on a year-over-year basis. Equities analysts anticipate that CVS Health Co. will post 6.51 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 1st. Investors of record on Monday, July 22nd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.59%. The ex-dividend date of this dividend was Monday, July 22nd. CVS Health’s payout ratio is presently 46.75%.

Analysts Set New Price Targets

A number of brokerages have issued reports on CVS. Baird R W upgraded CVS Health to a “hold” rating in a research report on Thursday, May 30th. Evercore ISI decreased their target price on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a research report on Thursday, August 8th. Royal Bank of Canada restated an “outperform” rating and set a $68.00 price target on shares of CVS Health in a research report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a report on Friday, August 9th. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $62.00 target price on shares of CVS Health in a report on Tuesday, September 10th. Eleven equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $72.10.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.